Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh.
Van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, Ahmed KM, Gelman A, Stute M, Simpson HJ, Wallace S, Small C, Parvez F, Slavkovich V, Loiacono NJ, Becker M, Cheng Z, Momotaj H, Shahnewaz M, Seddique AA, Graziano JH. Van Geen A, et al. Among authors: dhar rk. Bull World Health Organ. 2002;80(9):732-7. Bull World Health Organ. 2002. PMID: 12378292 Free PMC article.
Status of groundwater arsenic contamination in Bangladesh: a 14-year study report.
Chakraborti D, Rahman MM, Das B, Murrill M, Dey S, Chandra Mukherjee S, Dhar RK, Biswas BK, Chowdhury UK, Roy S, Sorif S, Selim M, Rahman M, Quamruzzaman Q. Chakraborti D, et al. Among authors: dhar rk. Water Res. 2010 Nov;44(19):5789-802. doi: 10.1016/j.watres.2010.06.051. Epub 2010 Jun 30. Water Res. 2010. PMID: 20684969
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M; SPIRIT-P2 Study Group. Nash P, et al. Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24. Lancet. 2017. PMID: 28551073 Clinical Trial.
2-[3-(Naphthalen-2-yl)phen-yl]naph-thal-ene.
Wolfenden ML, Dhar RK, Fronczek FR, Watkins SF. Wolfenden ML, et al. Among authors: dhar rk. Acta Crystallogr Sect E Struct Rep Online. 2013 Feb 1;69(Pt 2):o308. doi: 10.1107/S1600536813002390. Epub 2013 Jan 31. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 23424573 Free PMC article.
1-[3-(Naphthalen-1-yl)phen-yl]naphthal-ene.
Tummala M, Dhar RK, Fronczek FR, Watkins SF. Tummala M, et al. Among authors: dhar rk. Acta Crystallogr Sect E Struct Rep Online. 2013 Feb 1;69(Pt 2):o307. doi: 10.1107/S1600536813002407. Epub 2013 Jan 31. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 23424572 Free PMC article.
12 results